SynBioBeta 2025

Protein engineering is the most active frontier for AI in biotech. We are seeing the emergence of models that can make “zero shot” predictions of antibodies, and new variants of enzymes that would take millions of years for Evolution to produce. How should we be evaluating these models and their designs? What can we expect from the field of AI protein design moving forward?

This panel will bring together leaders across industry, public sector and the community to examine the systemic barriers slowing the bioeconomy’s growth and ask, “What best practices are we seeing to unlock progress?” Despite breakthroughs in synbio—including our recent research findings showing 96% of businesses are advancing biosolutions—progress remains stalled by discovery costs, scaling challenges, regulatory uncertainty, and investment bottlenecks. Join this session to understand how these challenges are being overcome to ensure synbio moves from future predictions to large-scale impact. The discussion will focus on tangible actions to accelerate this transition and realize the full economic promise of the bioeconomy.